A college football player in the Inland Empire isn’t letting his cancer diagnosis stop him from pursuing his passion. Torryn ...

Social Vulnerability Index scores inversely correlated with dietary fiber intake, suggesting social determinants may shape diet patterns relevant to microbiome-associated immunotherapy response. Whole ...

A randomized phase 2 maintenance strategy with cabozantinib 60 mg daily for up to 2 years failed to improve 4-month PFS versus placebo in high-grade uterine sarcomas. Median PFS was identical at 3.7 ...

Maariya Khan was left with minimal movement after needing surgery following her cancer diagnosis.

A United States-based Nigerian cancer scientist, Rahmon Kanmodi, has called for increased investment in musculoskeletal cancer research across Africa, with particular focus on Nigeria.Kanmodi, a ...

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best get-rich-quick stocks to buy according to hedge funds. On ...

Among the key speakers was Associate Professor Johnny Ong, Head and Senior Consultant of the Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT) at the National Cancer Cen ...

Miracle Trial Preliminary Blinded CRc Rate of 40% in First 30 Patients Suggests Encouraging Early Results in Relapsed/Refractory AMLHOUSTON, ...

Adherence to Clinical Practice Guidelines in the management of rare cancers remains inconsistent across Europe despite demonstrably improving patient outcomes, shows an analysis jointly conducted by ...

The company will now assess the available data to determine its next steps in progressing efti’s development across multiple ...

Miracle Trial Preliminary Blinded CRc Rate of 40% in First 30 Patients Suggests Encouraging Early Results in Relapsed/Refractory AML HOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc.